BCN BIOSCIENCES L L C has a total of 11 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, environmental technology and organic fine chemistry are ULTUPHARMA AB, CALIXA THERAPEUTICS INC and CBA PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Climate change adaptation technologies | |
#3 | Therapeutic chemical compounds | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Norris Andrew J | 9 |
#2 | Chakrabortty Sudip | 2 |
#3 | Andrew J Norris | 1 |
#4 | Norris Andrew | 1 |
#5 | Subhrajit Saha | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021041347A1 | Methods of treatment using bcn057 and bcn512 | |
WO2019032739A1 | Methods of treating radiation induced gastrointestinal syndrome (rigs) and related disease states using compound 512 | |
EP3525787A1 | Methods of treatment and pharmaceutical compositions using bcn057 or bcn512 |